Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women

Bibliography

• ORENSTEIN R, WONG ES: Urinary tract infections in adults. Am. Fam. Physician (1999) 59(5):1225–1234; 1237.
   Google Scholar
• PATTON JP, NASH DB, ABRUTYN E: Urinary tract infection: economic considerations. Med. Chh. North Am. (1991) 75(2):495–513.
   PubMedGoogle Scholar
• KUNIN CM: Urinary tract infections in females. Clin. Infect. Dis. (1994) 18(1):1–10.
   PubMed Web of Science ®Google Scholar
• HOOTON TM, SCHOLES D, HUGHES JP et al.: A prospective study of risk factors for symptomatic urinary tract infection in young women. N. Engl. J. Med. (1996) 335(7):468–474.
   PubMed Web of Science ®Google Scholar
• NEU HC: Optimal characteristics of agents to treat uncomplicated urinary tract infections. Infection (1992) 20\(Suppl. 4):S266–271.
   Google Scholar
• BAILEY RR: Duration of antimicrobial treatment and the use of drug combinations for the treatment of uncomplicated acute pyelonephritis. Infection. (1994) 22\(Suppl. 1):S50–52.
   Google Scholar
• TALAN DA, STAMM WE, HOOTON TM et al.: Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA (2000) 283(12):1583–1590.
   PubMedGoogle Scholar
• •Large, randomised trial of acute pyelonephritis in US, 1994-1997.
   Google Scholar
• DYER IE, SANKARY TM, DAWSON JA: Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997. West J. Med (1998) 169(5):265–268.
   PubMedGoogle Scholar
• GUPTA D, SCHOLES D, STAMM W: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA (1999) 281(8):736–738.
   PubMed Web of Science ®Google Scholar
• •Recent analysis of resistance issues in treatment of uncomplicated UTIs.
   Google Scholar
• ORRETT FA, SHURLAND SM: The changing patterns of antimicrobial susceptibility of urinary pathogens in Trinidad. Singapore Med. J. (1998) 39(6):256–259.
   PubMedGoogle Scholar
• THOMSON KS, SANDERS WE, SANDERS CC: USA resistance patterns among UTI pathogens. J. Antimicrob. Chemother (1994) 33(Suppl. A):9–15.
   Google Scholar
• ZHANEL GG, KARLOWSKY JA, HARDING GK et al: A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob. Agents Chemother. (2000) 44(4):1089–1092.
   PubMed Web of Science ®Google Scholar
• PEREZ-TRALLERO E, URBIETA M, JIMENEZ D et al.: Ten-year survey of quinolone resistance in Escherichia coil causing urinary tract infections. Eur. j Chit. Microbial. Infect. DS. (1993) 12(5):349–351.
   PubMedGoogle Scholar
• IQBAL J, RAHMAN M, KABIR MS: Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Bangladesh. Jim J. Med. Sci. Biol. (1997) 50(6):241–250.
   PubMedGoogle Scholar
• CORMICAN M, MORRIS D, CORBETT-FEEENEY G etal.: Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection. Diagn. 11/licrobiol. Infect. Dis. (1998) 32(4):317–319.
   Google Scholar
• BHAT KG, NINAN R, MALLYA S: Fluoroquinolone resistant bacteria in nosocomial UTI. Trop. Doti. (1998) 28(4):250–251.
   PubMedGoogle Scholar
• WOLFSON JS, HOOPER DC: Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis. Antimicrob. Agents Chemother. (1989) 33(10):1655–1661.
   PubMedGoogle Scholar
• STAMEY TA, FAIR WR, TIMOTHY MM et al.: Serum versus urinary antimicrobial concentrations in cure of urinary- tract infections. N Engl. J. Med. (1974) 291(22):1159–1163.
   PubMed Web of Science ®Google Scholar
• ANDRIOLE V: The Quinolones. Andriole V (Ed.), Academic Press, San Diego, London, Boston, New York, Sidney, Tokyo, Toronto (1998).
   Google Scholar
• •A thorough review of fluoroquinolones.
   Google Scholar
• EDLUND C, NORD CE: A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora. Infection (1988) 16(1):8–12.
   PubMedGoogle Scholar
• HOOTON TM, STAMM WE: Diagnosis and treatment of uncomplicated urinary tract infection. Infect. Dis. Chit. North Am. (1997) 11(3):551–581.
   PubMed Web of Science ®Google Scholar
• ••Comprehensive review of uncomplicatedUTIs.
   Google Scholar
• DAVEY P, STEINKE D, MACDONALD T et al.: Not so simple cystitis: how should prescribers be supported to make informed decisions about the increasing prevalence of infections caused by drug-resistant bacteria? Br. J. Gen. Pract. (2000) 50(451):143–146.
   Google Scholar
• GOLDSTEIN EJ, ALPERT ML, GINSBERG BP: Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections. Antimicrob. Agents Chemother (1985) 27(3):422–423.
   PubMedGoogle Scholar
• HOOTON TM, LATHAM RH, WONG ES et al.: Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. Antimicrob. Agents Chemother. (1989) 33(8):1308–1312.
   PubMedGoogle Scholar
• •Large, randomised trial comparing ofloxacin with TMP-SMX.
   Google Scholar
• HOOTON TM, JOHNSON C, WINTER C et al.: Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob. Agents Chemother (1991) 35(7):1479–1483.
   PubMedGoogle Scholar
• •Large, randomised trial comparing single-dose fluoroquinolone with TMP-SMX.
   Google Scholar
• HOOTON TM, WINTER C, TIU F et al: Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA (1995) 273(1):41–45.
   PubMed Web of Science ®Google Scholar
• MASTERTON RG, BOCHSLER JA: High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women. J. Antimicrob. Chemother (1995) 35(1):129–137.
   PubMed Web of Science ®Google Scholar
• MCCARTY JM, RICHARD G, HUCK W etal.: A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprimi sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am. J. Med. (1999) 106(3):292–299.
   Google Scholar
• ODE B, WALDER M, FORSGREN A: Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females. Scam/. J. Infect. Dis. (1987) 19(6):677–679.
   PubMed Web of Science ®Google Scholar
• WRIGHT SW, WRENN KD, HAYNES ML: Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J. Gen. Intern. Med (1999) 14(10):606–609.
   PubMed Web of Science ®Google Scholar
• WARREN JW, ABRUTYN E, HEBEL JR etal.: Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Chit. Infect. Dis. (1999) 29(4):745–758.
   Google Scholar
• ••Large meta-analysis and review of currentliterature on acute UTIs.
   Google Scholar
• MANDELL GL, BENNETT JE, DOLIN R: Mandell, Douglas and BermettS Principles and Practice of Infectious Disease(Edition 4; Volume 1). Mandell GL, Bennett JE, Dolin R (Eds.), Churchill Livingstone, New York, Edinburgh, London, Melbourne, Tokyo (1995).
   Google Scholar
• SAGINUR R, NICOLLE LE: Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Canadian Infectious Diseases Society Clinical Trials Study Group. Arch. Intern. Med (1992) 152(6):1233–1237.
   Google Scholar
• IRAVANI A, TICE AD, MCCARTY J et al.: Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group. Arch. Intern. Med (1995) 155(5):485–494.
   Google Scholar
• IRAVANI A: Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am. J. Med (1993) 94(3A):895–965.
   Google Scholar
• ARAV-BOGER R, LEIBOVICI L, DANON YL: Urinary tract infections with low and high colony counts in young women. Spontaneous remission and single-dose vs. multiple-day treatment. Arch. Intern. Med (1994) 154(3):300–304.
   Google Scholar
• LEELARASAMEE A, LEELARASAMEE I: Comparative efficacies of oral pefloxacin in uncomplicated cystitis. Single dose or 3-day therapy. Drugs (1995) 49\(Suppl. 2)365–367.
   Google Scholar
• PETERSEN EE, WINGEN F, FAIRCHILD KL et al: Single dose pefloxacin compared with multiple dose co-trimoxazole in cystitis. I Antimicrob. Chemother. (1990) 26 (Suppl. B):147–152.
   Google Scholar
• DUBOIS J, ST-PIERRE C, AUGER P etal.: Single-dose pefloxacin vs. seven days of trimethoprim-sulfamethoxazole in uncomplicated infection of the lower urinary tract in women. Reviews of Infectious Diseases (1989) 11\(Suppl. 5):51343–1344. Abstract.
   Google Scholar
• JARDIN A, CESANA M: Randomized, double-blind comparison of single-dose regimens of rufloxacin and pefloxacin for acute uncomplicated cystitis in women. French Multicenter Urinary Tract Infection-Rufloxacin Group. Antimicrob. Agents Chemother. (1995) 39(1):215–220.
   PubMedGoogle Scholar
• Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. The Inter-Nordic Urinary Tract Infection Study Group. Land. j Infect. Dis. (1988) 20(6):619–624.
   Google Scholar
• PIIPPO T, PITKAJARVI T, SALO SA: Three-day versus seven-day treatment with norfloxacin in acute cystitis. Cum: Ther. Res. (1990) 47(4):644–653.
   Google Scholar
• NERINGER R, FORSGREN A, HANSSON C et al.: Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group. Scand. Infect. Dis. (1992) 24(6):773–780.
   Google Scholar
• BLOCK JM, WALSTAD RA, BJERTNAES A et al.: Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. Drugs (1987) 34\(Suppl. 1):100–106.
   Google Scholar
• Fosfomycin for urinary tract infections. Med. Lett. Drugs The': (1997) 39(1005):66–68.
   Google Scholar
• BOEREMA JB, WILLEMS FT: Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice. Infection (1990) 18\(Suppl. 2):S80–88.
   Google Scholar
• DE JONG Z, PONTONNIER F, PLANTE P: Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections. Ural. Irk (1991) 46(4):344–348.
   PubMedGoogle Scholar
• STEIN GE: Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin. Ther. (1999) 21(10:1864–1872.
   PubMedGoogle Scholar
• BRITTAIN DC, SCULLY BE, HIROSE T et al.: The pharmacokinetic and bactericidal characteristics of oral cefixime. Pharmacal. The': (1985) 38(5):590–594.
   Google Scholar
• RAZ R, ROTTENSTERICH E, LESHEM Y: Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women. Antimicrob. Agents Chemother. (1994) 38(5):1176–1177.
   PubMed Web of Science ®Google Scholar
• COX CE, GRAVELINE JF, LUONGO JM: Review of clinical experience in the United States with cefpodoxime proxetil in adults with uncomplicated urinary tract infections. Drugs (1991) 42\(Suppl. 3):41–50.
   Google Scholar
• JOHNSON JR, LYONS MFD, PEARCE W et al.: Therapy for women hospitalized with acute pyelonephritis: a randomized trial of ampicillin versus trimethoprim-sulfamethoxazole for 14 days. j Infect. Dis. (1991) 163(2):325–330.
   PubMedGoogle Scholar
• STAMM WE, MCKEVITT M, COUNTS GW: Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial. Ann. Intern. Med. (1987) 106(3):341–345.
   PubMed Web of Science ®Google Scholar
• •Initial study comparing the efficacy of TMP-SMX and ampicillin in treatment of acute pyelonephritis.
   Google Scholar
• JERNELIUS H, ZBORNIK J, BAUER CA: One or three weeks' treatment of acute pyelonephritis? A double-blind comparison, using a fixed combination of pivampicillin plus pivmecillinam. Acta Med. Scand (1988) 223(5):469–477.
   PubMedGoogle Scholar
• •Initial study documenting treatment courses greater than 1 week to be optimal for treatment of acute uncomplicated pyelonephritis.
   Google Scholar
• MANNISTO P: The effect of crystal size, gastric content and emptying rate on the absorption of nitrofurantoin in healthy human volunteers. Int. j Chia. Pharmacal. Biopharm. (1978) 16(5):223–228.
   Google Scholar
• STEIN GE, MUMMAW N, GOLDSTEIN EJ et al: A multicenter comparative trial of three-day norfloxacin vs. ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections. Arch. Intern. Med (1987) 147(10):1760–1762.
   Google Scholar
• JONES RN, KUGLER KC, PFALLER MA et al.: Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn. Microbial Infect. Dis. (1999) 35 (1):55–63.
   PubMed Web of Science ®Google Scholar
• VANCE-BRYAN K, GUAY DR, ROTSCHAFER JC: Clinical pharmacokinetics of ciprofloxacin. Pharmacy/drier (1990) 19(6):434–461.
   Google Scholar
• BERGAN T, DALHOFF A, ROHWEDDER R: Pharmacokinetics of ciprofloxacin. Infection (1988) 16\(Suppl. 1):53–13.
   Google Scholar
• NABRE KG, THEURETZBACHER U, MONEVA-KOUCHEVA G et al: Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin. Eur. Infect. Dis. (1999) 18(11):783–789.
   Google Scholar
• PERRY CM, BARMAN BALFOUR JA, LAMB HM: Gatifloxacin. Drugs (1999) 58(4):683–696.
   PubMedGoogle Scholar
• DAVIS R, BRYSON HM: Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs (1994) 47(4):677–700.
   Google Scholar
• FISH DN, CHOW AT: The clinical pharmacokinetics of levofloxacin. Pharmacy/drier (1997) 32(2):101–119.
   Google Scholar
• HOLMES B, BROGDEN RN, RICHARDS DM: Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1985) 30(6):482–513.
   Google Scholar
• MONK JP, CAMPOLI-RICHARDS DM: Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1987) 33(4):46–91.
   Google Scholar
• TURNIDGE J: Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs (1999) 58\(Suppl. 2):29–36.
   Google Scholar